The White House on Tuesday responded to concerns voiced by a Moderna executive who suggested the current vaccines slotted to fight the coronavirus will not be enough to counter the new omicron ...

"Bivalent" means it's half original strain, and half Omicron BA.4, BA.5. The only bivalent boosters currently authorized are mRNA versions—one by Pfizer, another by Moderna—and this is the first time ...

Moderna has started human trials of an Omicron version of its COVID-19 vaccine SpikeVax, just in case a modified version will be needed to boost protection against the new variant later this year.

Omicron: How worried should we be ... There was not enough data to analyse the Moderna or Janssen vaccines, but there is no reason to think they would have different results.

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

Moderna yesterday announced that it has submitted an application to the Food and Drug Administration (FDA) for emergency use of its bivalent (two-strain) COVID booster vaccine that targets the BA.4/BA ...

Moderna Inc. said Thursday a Phase 3 trial of ... which showed that mRNA-1283 had higher neutralizing antibody responses against both Omicron BA.4/5 and ancestral SARS-CoV-2 than mRNA-1273 ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Moderna Inc. announced Tuesday that its next ... as it demonstrated a higher immune response against the Omicron BA.4/BA.5 ...

The new bivalent (two-strain) Moderna COVID-19 vaccine booster triggered stronger neutralizing antibody responses against the highly transmissible Omicron variant at 28 days than the previously ...

US company Moderna is planning to begin trials of its own Omicron-specific shot soon. Oxford University and AstraZeneca have also started working on a new version of their vaccine. Vaccine ...